2024-07-16 16:38:53 ET
Summary
- Baxter has been a poor performer over the last year.
- The stock now trades with an extremely low valuation relative to the stock's historical performance.
- Recently, the company raised guidance, which points to double-digit earnings growth. Analysts seem to believe this growth is sustainable.
- Baxter has plans to sell its least profitable business to focus on higher margin segments.
Healthcare remains one of my favorite sectors to find names that offer growth and income due to the inelastic demand for products and services.
The steady nature of many companies in this sector paves the way for a return of capital through share repurchases and dividends....
Read the full article on Seeking Alpha
For further details see:
Baxter: Why Investors Should Take Advantage Of The Low Valuation